Share Prices & Company Research

Market News

24 Jul 2020 | 09:39

Creo Medical acquires European device manufacturer Albyn

(Sharecast News) - Medical device company Creo Medical Group acquired European manufacturer Albyn Medical on Friday for €24.8m plus as much as €2.7m in performance-related considerations over the next two years. Creo said Albyn, which supplies and manufactures gastroenterology, urology and endoscopy products, was a well-established and stable business and had remained profitable on a monthly basis during the Covid-19 pandemic.

The AIM-listed group stated the acquisition was a synergistic one, which provided it with immediate market access across Spain, France, Germany and the UK.

Chief executive Craig Gulliford said: "Albyn Medical is an exceptionally good fit with Creo.

"The enlarged business brings together a wide range of highly complementary GI products, with an opportunity to broaden the portfolio into urology, and provides us with an extensive marketing and sales capability to support our commercial presence in Europe and the roll-out of our innovative range of advanced energy devices."

As of 0940 BST, Creo Medical shares were untraded at 201p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 23rd October 2020
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.